122 related articles for article (PubMed ID: 2124694)
1. beta-Galactosidase containing a human immunodeficiency virus protease cleavage site is cleaved and inactivated by human immunodeficiency virus protease.
Baum EZ; Bebernitz GA; Gluzman Y
Proc Natl Acad Sci U S A; 1990 Dec; 87(24):10023-7. PubMed ID: 2124694
[TBL] [Abstract][Full Text] [Related]
2. Human T-cell leukemia virus type 1 protease protein expressed in Escherichia coli possesses aspartic proteinase activity.
Saiga A; Tanaka T; Orita S; Sato A; Sato S; Hachisu T; Abe K; Kimura Y; Kondo Y; Fujiwara T
Arch Virol; 1993; 128(3-4):195-210. PubMed ID: 8435041
[TBL] [Abstract][Full Text] [Related]
3. Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease.
Erickson-Viitanen S; Manfredi J; Viitanen P; Tribe DE; Tritch R; Hutchison CA; Loeb DD; Swanstrom R
AIDS Res Hum Retroviruses; 1989 Dec; 5(6):577-91. PubMed ID: 2692658
[TBL] [Abstract][Full Text] [Related]
4. Local and spatial factors determining HIV-1 protease substrate recognition.
Hazebrouck S; Machtelinckx-Delmas V; Kupiec JJ; Sonigo P
Biochem J; 2001 Sep; 358(Pt 2):505-10. PubMed ID: 11513751
[TBL] [Abstract][Full Text] [Related]
5. Autoprocessing of the human immunodeficiency virus type 1 protease precursor expressed in Escherichia coli from a synthetic gene.
Valverde V; Lemay P; Masson JM; Gay B; Boulanger P
J Gen Virol; 1992 Mar; 73 ( Pt 3)():639-51. PubMed ID: 1545221
[TBL] [Abstract][Full Text] [Related]
6. Model system for high-throughput screening of novel human immunodeficiency virus protease inhibitors in Escherichia coli.
Cheng TJ; Brik A; Wong CH; Kan CC
Antimicrob Agents Chemother; 2004 Jul; 48(7):2437-47. PubMed ID: 15215092
[TBL] [Abstract][Full Text] [Related]
7. Expression of functional beta-galactosidase containing the coxsackievirus 3C protease as an internal fusion.
Windheuser MG; Dwyer S; Dasmahapatra B
Biochem Biophys Res Commun; 1991 May; 177(1):243-51. PubMed ID: 1904218
[TBL] [Abstract][Full Text] [Related]
8. Purification of HIV-1 wild-type protease and characterization of proteolytically inactive HIV-1 protease mutants by pepstatin A affinity chromatography.
Wondrak EM; Louis JM; Mora PT; Oroszlan S
FEBS Lett; 1991 Mar; 280(2):347-50. PubMed ID: 2013336
[TBL] [Abstract][Full Text] [Related]
9. Investigating human immunodeficiency virus-1 proteinase specificity at positions P4 to P2 using a bacterial screening system.
Schlick P; Skern T
Anal Biochem; 2008 Jun; 377(2):162-9. PubMed ID: 18384738
[TBL] [Abstract][Full Text] [Related]
10. Sensitive genetic screen for protease activity based on a cyclic AMP signaling cascade in Escherichia coli.
Dautin N; Karimova G; Ullmann A; Ladant D
J Bacteriol; 2000 Dec; 182(24):7060-6. PubMed ID: 11092869
[TBL] [Abstract][Full Text] [Related]
11. Novel bacteriological assay for detection of potential antiviral agents.
Block TM; Grafstrom RH
Antimicrob Agents Chemother; 1990 Dec; 34(12):2337-41. PubMed ID: 2088188
[TBL] [Abstract][Full Text] [Related]
12. Conversion of thymidylate synthase into an HIV protease substrate.
Kupiec JJ; Hazebrouck S; Leste-Lasserre T; Sonigo P
J Biol Chem; 1996 Aug; 271(31):18465-70. PubMed ID: 8702491
[TBL] [Abstract][Full Text] [Related]
13. Kinetics and mechanism of autoprocessing of human immunodeficiency virus type 1 protease from an analog of the Gag-Pol polyprotein.
Louis JM; Nashed NT; Parris KD; Kimmel AR; Jerina DM
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7970-4. PubMed ID: 8058744
[TBL] [Abstract][Full Text] [Related]
14. Intrinsic activity of human immunodeficiency virus type 1 protease heterologous fusion proteins in mammalian cells.
Arrigo SJ; Haines JK; Huffman KM
DNA Cell Biol; 1995 Jan; 14(1):15-23. PubMed ID: 7832989
[TBL] [Abstract][Full Text] [Related]
15. HIV protease-activated molecular switches based on beta-glucuronidase and alkaline phosphatase.
O'Loughlin TL; Matsumura I
Comb Chem High Throughput Screen; 2006 May; 9(4):313-20. PubMed ID: 16724922
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of human immunodeficiency virus type 1 protease increases intracellular cleavage of Gag and reduces virus infectivity.
Luukkonen BG; Fenyö EM; Schwartz S
Virology; 1995 Feb; 206(2):854-65. PubMed ID: 7856098
[TBL] [Abstract][Full Text] [Related]
17. Multiple replacements establish the importance of tyrosine-503 in beta-galactosidase (Escherichia coli).
Ring M; Huber RE
Arch Biochem Biophys; 1990 Dec; 283(2):342-50. PubMed ID: 2125820
[TBL] [Abstract][Full Text] [Related]
18. High-level expression and purification of mature HIV-1 protease in Escherichia coli under control of the araBAD promoter.
Taylor A; Brown DP; Kadam S; Maus M; Kohlbrenner WE; Weigl D; Turon MC; Katz L
Appl Microbiol Biotechnol; 1992 May; 37(2):205-10. PubMed ID: 1368241
[TBL] [Abstract][Full Text] [Related]
19. Construction of infectious molecular clones of HIV-1 containing defined mutations in the protease gene.
Winslow DL; Anton ED; Horlick RA; Zagursky RJ; Tritch RJ; Scarnati H; Ackerman K; Bacheler LT
Biochem Biophys Res Commun; 1994 Dec; 205(3):1651-7. PubMed ID: 7811249
[TBL] [Abstract][Full Text] [Related]
20. A set of beta-galactosidase gene fusion cassettes demonstrates usefulness in expressing HIV-1 genes in Escherichia coli.
Valverde V; Duplan H; Knibiehler M; Masson JM
Plasmid; 1994 Jul; 32(1):32-40. PubMed ID: 7991670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
